AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion Both companies knock down rumors that the biotech is being acquired

https://www.statnews.com/2026/03/29/insilico-medicine-lilly-sign-ai-drug-commercialization-deal/ By Brittany TrangMarch 29, 2026 Health Tech Reporter